VCAM1 and acute lymphoblastic leukemia: This could be due to the better capacity of Jurkat cells to attach to VCAM-1, suggesting that VCAM-1-induced chemoresistance could be more relevant for T-ALL patients displaying high levels of α4 and greater abilities to attach to VCAM-1.